Huntington's disease (HD) is a progressive neurological disorder that affects movement, cognition, and emotional regulation. It is caused by a genetic mutation that leads to the degeneration of brain cells, resulting in a wide range of symptoms that worsen over time. While there is currently no cure for Huntington's disease, various treatments and support systems are available to help manage symptoms and improve quality of life for affected individuals and their families.
Last updated on : 18 Dec, 2024
Read time : 15 mins
Huntington's disease (HD) is a complex neurological condition that has a profound impact on the lives of those affected and their loved ones. This inherited disorder is caused by a genetic mutation that leads to the progressive deterioration of brain cells, particularly in regions responsible for controlling voluntary movements and memory. As the disease progresses, individuals with HD experience a wide range of symptoms that can significantly affect their daily functioning and overall quality of life. Understanding the causes, symptoms, and available support options is crucial for those facing the challenges of Huntington's disease.
Huntington's disease is a neurodegenerative disorder that causes the progressive breakdown of nerve cells in the brain. The condition is caused by a mutation in the huntingtin (HTT) gene, which provides instructions for making a protein called huntingtin. The mutated gene produces an abnormal form of the protein, which accumulates in the brain and disrupts normal brain function. As the disease progresses, it leads to increasingly severe symptoms that affect a person's physical, mental, and emotional well-being. While there is currently no cure for Huntington's disease, treatments are available to help manage symptoms and improve quality of life.
Category | Details |
Also Referred as | Huntington's chorea, Huntington chronic progressive hereditary disease |
Commonly Occurs In | Adults, Children, Adolescents |
Affected Organ | Brain |
Type | Neurological disorder, Movement disorder |
Common Signs | Involuntary muscle movements (chorea), Mental deterioration, Weight loss, Cognitive decline |
Consulting Specialist | Neurologist, Psychiatrist, Genetic counsellor, Speech pathologist |
Treatement Procedures | Medication for symptoms, Speech therapy, Occupational therapy, Regular exercise |
Managed By | Anticonvulsants, VMAT2 inhibitors |
Mimiciking Condition | Other movement disorders, Neurodegenerative diseases |
Huntington's disease is categorised into two main types based on age of onset, including:
Adult-Onset Huntington's Disease: Adult-onset HD typically appears between ages 30 and 50. Initial symptoms include mood changes, concentration difficulties, and involuntary movements (chorea). As it progresses, individuals face severe motor, cognitive, and emotional decline, usually over 15 to 20 years.
Juvenile Huntington's Disease: Juvenile HD occurs in individuals under 20. Symptoms include severe motor dysfunction, cognitive decline, and behavioural changes, often progressing more rapidly than adult-onset HD. Early diagnosis and intervention are crucial for effective management.
The early signs of Huntington's disease may include:
Challenges with attention and focus
Episodes of forgetfulness
Depression, including feelings of sadness and hopelessness
Frequent stumbling
Emotional fluctuations, such as irritability or aggressive outbursts
The symptoms of Huntington's disease can vary from person to person, including:
Huntington's disease progresses through distinct stages, each characterised by specific challenges. These include:
Stage I (0 to 8 years from illness onset): In stage I, individuals may experience subtle behavioural changes and mild motor symptoms. This stage is often characterised by a lack of awareness about the disease, leading to initial confusion and frustration as the symptoms begin to manifest.
Stage II (3 to 13 years from illness onset): During stage II, symptoms become more pronounced, including mood swings and difficulties with coordination. Individuals may struggle with daily tasks, and this stage often involves increased emotional strain on both patients and their families as they adapt to these changes.
Stage III (5 to 16 years from illness onset): Stage III is marked by significant cognitive and motor decline. Individuals may experience involuntary movements, memory loss, and challenges in communication. This stage can create additional emotional distress, necessitating greater support from caregivers and loved ones.
Stage IV (9 to 21 years from illness onset): In stage IV, individuals face severe limitations in mobility and cognitive function. Daily activities become increasingly challenging, requiring extensive assistance. This stage emphasises the need for patience and support as both patients and caregivers navigate the complexities of advanced HD.
Stage V (11 to 26 years from illness onset): The final stage of HD often involves profound physical and cognitive impairment, leading to complete dependence on caregivers. Quality of life becomes a primary focus as families seek to provide comfort and dignity for their loved ones during this advanced stage of the disease.
The causes of Huntington's disease involve specific genetic and molecular changes, including:
Genetic Mutation: Huntington's disease is caused by a mutation in the HTT gene on chromosome 4, resulting in an abnormal form of the huntingtin protein.
CAG Repeats: The mutation involves an expanded CAG repeat sequence in the HTT gene. While the normal sequence is repeated 10 to 35 times, in Huntington's disease it is repeated 36 or more times.
Inherited Condition: Huntington's disease is inherited in an autosomal dominant pattern, meaning that inheriting one copy of the mutated gene from either parent will cause the disease. Each child of an affected parent has a 50% chance of inheriting the mutation.
Protein Aggregation: The abnormal huntingtin protein forms toxic aggregates in brain cells, disrupting their normal function and leading to damage.
Neuronal Death: These toxic protein aggregates cause progressive neuronal death, particularly in the basal ganglia and cortex, leading to the characteristic motor, cognitive, and psychiatric symptoms of the disease.
The risk factors of Huntington's disease include:
Genetic mutation in the HTT gene
Family history of Huntington's disease
Age of onset (typically 30-50 years old)
Autosomal dominant inheritance pattern
Expansion of CAG repeats in the HTT gene
Family history of neurological disorders
Presence of symptoms in close relatives
People at risk for Huntington's disease typically include:
Individuals with a parent who has Huntington's disease
Those with a known mutation in the HTT gene
People with a family history of the disease
Individuals experiencing early-onset symptoms
Siblings of affected individuals
It is important to note that having a family history of Huntington's disease does not necessarily mean that an individual will develop the condition. However, those at risk may consider genetic testing and counselling to make informed decisions about their health and future.
Huntington's disease can lead to a range of complications that significantly impact an individual's quality of life. These include:
Currently, there is no known way to prevent Huntington's disease due to its genetic nature. However, there are some strategies that can be considered:
Genetic Counselling and Testing: Individuals with a family history of Huntington's disease may benefit from genetic counselling to understand their risk and options. Genetic testing can determine if someone carries the mutated HTT gene.
Family Planning: For those at risk, family planning options such as preimplantation genetic diagnosis (PGD) can help prevent passing the mutation to future generations by selecting embryos without the gene mutation.
Research Participation: Participating in research studies and clinical trials may provide access to new treatments and contribute to the development of potential preventive measures.
Early Intervention: Early diagnosis and intervention can help manage symptoms more effectively and improve the quality of life, though this does not prevent the disease itself.
Diagnosing Huntington's disease typically involves a combination of several steps:
Clinical Examination: Your doctor will perform a detailed physical and neurological exam to assess your motor abilities and cognitive functions.
Family History: Having a family history of Huntington's disease is often the biggest clue in diagnosing the condition.
Genetic Testing: Special blood tests can determine your likelihood of developing Huntington's disease by identifying the presence of the mutated huntingtin gene.
Imaging Tests: Computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, or positron emission tomography (PET) scans may be used to evaluate brain damage and tissue loss associated with Huntington's disease.
Early signs of Huntington's disease may include subtle changes in coordination, involuntary movements (chorea), difficulty concentrating or remembering information, depression, and mood swings. If you notice any of these symptoms, especially if you have a family history of the condition, consult your doctor for further evaluation.
While there is currently no cure for Huntington's disease, various treatment options are available to help manage symptoms and improve quality of life. Treatment typically involves a multidisciplinary approach, including medical interventions, lifestyle modifications, and supportive therapies.
Several medications are used to manage the symptoms of Huntington's disease. Dopamine antagonists such as haloperidol and tetrabenazine are helpful in controlling the unusual movements caused by the condition. Antipsychotic medications and dopamine receptor antagonists are also prescribed to treat psychiatric symptoms like hallucinations and delusional thoughts. To manage depression and mood swings, healthcare providers may recommend antidepressants and mood stabilisers. VMAT2 inhibitors, including tetrabenazine, deutetrabenazine, and valbenazine, are used to treat chorea, while anticonvulsants such as valproic acid and clonazepam help manage muscle spasms. Additionally, dopamine-depleting agents like reserpine are used to reduce dopamine levels in the brain, which aids in controlling chorea. These medications play a crucial role in improving the quality of life for individuals with Huntington's disease by effectively managing their symptoms. However, it is essential to consult a doctor to determine the best course of treatment based on the individual's specific needs and the severity of their condition.
Living with Huntington's disease presents significant challenges as the condition progresses. This may include:
If you have been diagnosed with Huntington's disease, it is crucial to maintain regular follow-up appointments with your doctor to closely monitor your condition. Seek immediate medical attention if you experience worsening symptoms, such as increasing difficulty with motor tasks like walking or balance, trouble swallowing or choking while eating, significant mood changes including depression or suicidal thoughts, rapid weight loss or difficulty maintaining a healthy weight, or severe behavioural changes and agitation. Your doctor can assess these symptoms, adjust your treatment plan as needed, and offer guidance on managing the disease effectively. They may also refer you to specialists such as neurologists, psychiatrists, or physical therapists to address specific aspects of your care. Remember, early intervention and consistent medical care are essential for maintaining the best possible quality of life when living with Huntington's disease.
Huntington's disease is a genetic disorder characterised by movement disorders, cognitive decline, and psychiatric symptoms.
The disease is caused by a defective gene that leads to the production of an abnormal protein, which accumulates in the brain and causes damage to nerve cells.
Early signs of Huntington's disease may include subtle changes in mood, cognition, and motor skills.
The diagnosis of Huntington's disease involves genetic testing, neurological examinations, and brain imaging.
There is currently no cure for Huntington's disease, but medications and supportive therapies can help manage symptoms and improve quality of life.
Dopamine-depleting agents and anticonvulsants are commonly used to manage chorea and muscle spasms, while dopamine receptor antagonists can be used as second-line therapy for chorea relief.
Early diagnosis and appropriate treatment can significantly improve the quality of life for patients with Huntington's disease.
Regular follow-up appointments with doctors are essential to monitor the progression of the disease and adjust treatment as needed.
The median life expectancy for Huntington's disease is around 15–18 years after symptom onset, but it can range from 5 to over 25 years for adult-onset HD.
Currently, there is no cure for Huntington's disease, as it is a progressive condition that worsens over time.
Juvenile Huntington's disease, which affects children and teenagers, is the youngest form of the condition, with an average life expectancy of 10-15 years after symptom onset.
Recovery from Huntington's disease is not possible, as it is a degenerative condition that progresses over time, eventually requiring full-time care.
Prevention of Huntington's disease is not possible in individuals who have inherited the defective gene; however, genetic testing and reproductive options like preimplantation genetic diagnosis (PGD) can help identify and avoid passing the gene to offspring.
The average age of onset for Huntington's disease is around 45 years, but approximately 25% of affected individuals do not experience symptoms until after the age of 50. Juvenile Huntington's disease begins before the age of 20 and accounts for about 10% of cases.
In the final stages of Huntington's disease, individuals experience severe physical and cognitive decline, often leading to difficulties with swallowing, breathing, and mobility. They become completely dependent on care providers and require full-time care.
Alzheimer's Association. (n.d.). Huntington's disease. https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/huntington-s-disease
MedlinePlus. (2023). Huntington disease. https://medlineplus.gov/genetics/condition/huntingtons-disease/
Johns Hopkins Medicine. (n.d.). Huntington's disease. https://www.hopkinsmedicine.org/health/conditions-and-diseases/huntingtons-disease
National Institute of Neurological Disorders and Stroke. (n.d.). Huntington's disease. https://www.ninds.nih.gov/health-information/disorders/huntingtons-disease
...View more
...View more
Subscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.7.2
Our Payment Partners